Health Affairs, 25, no. 5 (2006): 1332-1339 doi: 10.1377/hlthaff.25.5.1332 © 2006 by Project HOPE	New Online   Pay Cuts For Medicare Docs   Access To Care Woes   Public Coverage More Efficient   Empowering Consumers

This Article Figures Only Full Text (HTML) Reprint (PDF) Submit a response to this article Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via ISI Web of Science (2) Citing Articles via Google Scholar Google Scholar Articles by Mullins, C. D. Articles by Caputo, N. Search for Related Content PubMed PubMed Citation Articles by Mullins, C. D. Articles by Caputo, N. Related Collections Insurance Market Access To Care Business Of Health Chronic Care Consumer Issues Insurance Coverage Managed Care Managed Care - Consumers Pharmaceuticals Quality Of Care Research And Technology Health Spending

Specialty Drugs

Health Plans’ Strategies For Managing Outpatient Specialty Pharmaceuticals

Balancing increased spending for specialty pharmaceuticals while providing affordable and equitable coverage for consumers is a key issue for public and private payers. Health plans rely on an array of strategies, including both medical management and those used for more traditional pharmaceuticals. To explore specific management strategies for outpatient specialty pharmaceuticals, a survey was administered to thirty-eight Blue Cross and Blue Shield plans, focused on identifying core strategies. Prior authorization was the most commonly used strategy, implemented by 83.3 percent of respondents. Other frequently implemented management strategies included claims review (82.8 percent), formulary management (76.7 percent), and utilization review (70 percent).

                      What's this?